Predictive models for mutations in mismatch repair genes: implication for genetic counseling in developing countries

BackgroundLynch syndrome (LS) is the most common form of inherited predisposition to colorectal cancer (CRC), accounting for 2-5% of all CRC. LS is an autosomal dominant disease characterized by mutations in the mismatch repair genes mutL homolog 1 (MLH1), mutS homolog 2 (MSH2), postmeiotic segregation increased 1 (PMS1), post-meiotic segregation increased 2 (PMS2) and mutS homolog 6 (MSH6). Mutation risk prediction models can be incorporated into clinical practice, facilitating the decision-making process and identifying individuals for molecular investigation. This is extremely important in countries with limited economic resources. This study aims to evaluate sensitivity and specificity of five predictive models for germline mutations in repair genes in a sample of individuals with suspected Lynch syndrome.MethodsBlood samples from 88 patients were analyzed through sequencing MLH1, MSH2 and MSH6 genes. The probability of detecting a mutation was calculated using the PREMM, Barnetson, MMRpro, Wijnen and Myriad models. To evaluate the sensitivity and specificity of the models, receiver operating characteristic curves were constructed.ResultsOf the 88 patients included in this analysis, 31 mutations were identified: 16 were found in the MSH2 gene, 15 in the MLH1 gene and no pathogenic mutations were identified in the MSH6 gene. It was observed that the AUC for the PREMM (0.846), Barnetson (0.850), MMRpro (0.821) and Wijnen (0.807) models did not present significant statistical difference. The Myriad model presented lower AUC (0.704) than the four other models evaluated. Considering thresholds of ≥ 5%, the models sensitivity varied between 1 (Myriad) and 0.87 (Wijnen) and specificity ranged from 0 (Myriad) to 0.38 (Barnetson).ConclusionsThe Barnetson, PREMM, MMRpro and Wijnen models present similar AUC. The AUC of the Myriad model is statistically inferior to the four other models.

[1]  A. Zwinderman,et al.  Clinical findings with implications for genetic testing in families with clustering of colorectal cancer. , 1998, The New England journal of medicine.

[2]  Julie O. Culver,et al.  Genetics, genomics, and cancer risk assessment , 2011, CA: a cancer journal for clinicians.

[3]  Chu Chen,et al.  Screening for Deleterious Nonsynonymous Single-Nucleotide Polymorphisms in Genes Involved in Steroid Hormone Metabolism and Response , 2005, Cancer Epidemiology Biomarkers & Prevention.

[4]  Andrew N Freedman,et al.  Cancer risk prediction models: a workshop on development, evaluation, and application. , 2005, Journal of the National Cancer Institute.

[5]  S. Pena,et al.  DNA tests probe the genomic ancestry of Brazilians. , 2009, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[6]  R. Hofstra,et al.  A database to support the interpretation of human mismatch repair gene variants , 2008, Human mutation.

[7]  A. Wielandt,et al.  Spectrum of MLH1 and MSH2 Mutations in Chilean Families With Suspected Lynch Syndrome , 2010, Diseases of the colon and rectum.

[8]  E. Steyerberg,et al.  Comparison of predictive models, clinical criteria and molecular tumour screening for the identification of patients with Lynch syndrome in a population-based cohort of colorectal cancer patients , 2008, Journal of Medical Genetics.

[9]  E. Kuipers,et al.  Mutation prediction models in Lynch syndrome: evaluation in a clinical genetic setting , 2009, Journal of Medical Genetics.

[10]  H. Lynch,et al.  Tumor variation in three extended Lynch syndrome II kindreds. , 1988, The American journal of gastroenterology.

[11]  Ewout W Steyerberg,et al.  Prediction of MLH1 and MSH2 mutations in Lynch syndrome. , 2006, JAMA.

[12]  W. Foulkes,et al.  A comparison of models used to predict MLH1, MSH2 and MSH6 mutation carriers. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[13]  J. Prolla,et al.  Identification of patients at-risk for Lynch syndrome in a hospital-based colorectal surgery clinic. , 2011, World journal of gastroenterology.

[14]  F. Couch,et al.  Assessment of functional effects of unclassified genetic variants , 2008, Human mutation.

[15]  A. Chapelle The Incidence of Lynch Syndrome , 2004, Familial Cancer.

[16]  H T Lynch,et al.  New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. , 1999, Gastroenterology.

[17]  A. Giraldo,et al.  MLH1 and MSH2 Mutations in Colombian Families with Hereditary Nonpolyposis Colorectal Cancer (Lynch syndrome) – Description of Four Novel Mutations , 2005, Familial Cancer.

[18]  J. Hanley,et al.  The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.

[19]  N. de Wind,et al.  Functional analysis helps to clarify the clinical importance of unclassified variants in DNA mismatch repair genes , 2007, Human mutation.

[20]  P. Peltomäki,et al.  Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer. , 1997, Gastroenterology.

[21]  P. Peltomäki Lynch Syndrome Genes , 2004, Familial Cancer.

[22]  Peter Beighton,et al.  de la Chapelle, A. , 1997 .

[23]  J. Mecklin,et al.  The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC) , 1991, Diseases of the colon and rectum.

[24]  Sudhir Srivastava,et al.  Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. , 2004, Journal of the National Cancer Institute.

[25]  H. Lynch,et al.  The Lynch syndromes , 1993, Current opinion in oncology.

[26]  G. Parmigiani,et al.  Whole pelvic helical tomotherapy for locally advanced cervical cancer: technical implementation of IMRT with helical tomothearapy , 2009, Radiation oncology.

[27]  R. Terracciano,et al.  A novel missense germline mutation in exon 2 of the hMSH2 gene in a HNPCC family from Southern Italy. , 2005, Cancer letters.

[28]  Harry Campbell,et al.  Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer. , 2006, The New England journal of medicine.

[29]  D. Grattapaglia,et al.  Genetic composition of Brazilian population samples based on a set of twenty‐eight ancestry informative SNPs , 2009, American journal of human biology : the official journal of the Human Biology Council.

[30]  D. Altman,et al.  Statistics Notes: Diagnostic tests 1: sensitivity and specificity , 1994 .

[31]  I. Tomlinson,et al.  Novel MLH1 duplication identified in Colombian families with Lynch syndrome , 2011, Genetics in Medicine.

[32]  D. Carraro,et al.  Characterization of germline mutations of MLH1 and MSH2 in unrelated south American suspected Lynch syndrome individuals , 2011, Familial Cancer.

[33]  H. Lynch,et al.  Colorectal and extracolonic cancer variations in MLH1/MSH2 hereditary nonpolyposis colorectal cancer kindreds and the general population , 1998, Diseases of the colon and rectum.

[34]  Tom Fawcett,et al.  An introduction to ROC analysis , 2006, Pattern Recognit. Lett..

[35]  D. Horsman,et al.  Validation of predictive models for germline mutations in DNA mismatch repair genes in colorectal cancer , 2009, International journal of cancer.

[36]  M. Woods,et al.  Prediction of Lynch syndrome in consecutive patients with colorectal cancer. , 2009, Journal of the National Cancer Institute.

[37]  Mev Dominguez Valentin,et al.  Frequency of extracolonic tumors in Brazilian families with Lynch syndrome: analysis of a hereditary colorectal cancer institutional registry , 2010, Familial Cancer.

[38]  E. DeLong,et al.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.

[39]  C. Boland,et al.  A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. , 1997, Journal of the National Cancer Institute.

[40]  E. Steyerberg,et al.  Validation and extension of the PREMM1,2 model in a population-based cohort of colorectal cancer patients. , 2008, Gastroenterology.

[41]  D. Marzese,et al.  MLPA mutation detection in Argentine HNPCC and FAP families , 2008, Familial Cancer.

[42]  G. Lenoir,et al.  Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO. , 2002, Journal of the National Cancer Institute.

[43]  H. Lynch,et al.  Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) in Argentina: Report from a Referral Hospital Register , 2007, Diseases of the colon and rectum.

[44]  Leila Mohammadi,et al.  BMC Cancer , 2001 .